John Law

490 total citations
16 papers, 325 citations indexed

About

John Law is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Law has authored 16 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 7 papers in Epidemiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Law's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). John Law is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). John Law collaborates with scholars based in Canada, United States and Australia. John Law's co-authors include Michael Houghton, D. Lorne Tyrrell, Michael Logan, Darren Hockman, Rodney S. Russell, Renske D.M. Steenbergen, Michael Joyce, Bradley Thomas, Daniel M. Jones and Juthika Kundu and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

John Law

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Law Canada 11 169 148 90 71 45 16 325
Weiping Qin Japan 5 227 1.3× 166 1.1× 137 1.5× 32 0.5× 24 0.5× 7 341
Jean–Marc Juteau United States 9 141 0.8× 205 1.4× 131 1.5× 15 0.2× 39 0.9× 14 428
Janina Bruening Germany 8 169 1.0× 101 0.7× 55 0.6× 31 0.4× 33 0.7× 11 313
Michel Ventura France 15 169 1.0× 136 0.9× 349 3.9× 52 0.7× 42 0.9× 28 585
О. В. Масалова Russia 11 138 0.8× 246 1.7× 164 1.8× 36 0.5× 98 2.2× 41 429
D.C. Pevear United States 7 93 0.6× 227 1.5× 96 1.1× 27 0.4× 37 0.8× 9 429
Romuald Patient France 11 452 2.7× 514 3.5× 113 1.3× 50 0.7× 71 1.6× 13 684
Karen Rigat United States 10 363 2.1× 262 1.8× 115 1.3× 46 0.6× 12 0.3× 13 511
Yann Ciczora France 5 308 1.8× 230 1.6× 80 0.9× 152 2.1× 23 0.5× 7 400
Elizabeth Atkins United Kingdom 8 79 0.5× 158 1.1× 53 0.6× 22 0.3× 33 0.7× 12 294

Countries citing papers authored by John Law

Since Specialization
Citations

This map shows the geographic impact of John Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Law more than expected).

Fields of papers citing papers by John Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Law. The network helps show where John Law may publish in the future.

Co-authorship network of co-authors of John Law

This figure shows the co-authorship network connecting the top 25 collaborators of John Law. A scholar is included among the top collaborators of John Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Law. John Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Law, John & Heidi E. Drummer. (2024). Bridging the gap: A new tool to down select HCV vaccine candidates. Hepatology. 80(5). 1006–1008. 1 indexed citations
2.
Kundu, Juthika, Thanh Hoa Le, Michael Logan, et al.. (2024). Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone. Journal of Hepatology. 81(6). 941–948. 4 indexed citations
3.
Liang, T. Jake, John Law, Thomas Pietschmann, et al.. (2023). Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model. Clinical Infectious Diseases. 77(Supplement_3). S257–S261. 4 indexed citations
4.
Kanai, Tapan, Zongyi Hu, Renbin Yang, et al.. (2022). Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis. Journal of Virology. 97(1). e0178822–e0178822. 1 indexed citations
6.
Schneider, Martina, T. Bakonyi, Stanislav Indik, et al.. (2019). Plasmid DNA contaminant in molecular reagents. Scientific Reports. 9(1). 1652–1652. 20 indexed citations
7.
Akache, Bassel, Lise Deschatelets, Blair A. Harrison, et al.. (2019). Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins. Vaccines. 7(4). 204–204. 25 indexed citations
8.
Law, John, Michael Logan, Jason Wong, et al.. (2018). Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine. Journal of Virology. 92(11). 35 indexed citations
9.
Landi, Abdolamir, John Law, Darren Hockman, et al.. (2017). Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Vaccine. 35(50). 6949–6956. 32 indexed citations
10.
Logan, Michael, John Law, Jason Wong, et al.. (2016). Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG. Journal of Virology. 91(1). 34 indexed citations
11.
O’Shea, Daire, John Law, Adrian Egli, et al.. (2015). Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate. Liver Transplantation. 22(3). 324–332. 14 indexed citations
12.
Law, John, Juan Jovel, Jordan Patterson, et al.. (2013). Identification of Hepatotropic Viruses from Plasma Using Deep Sequencing: A Next Generation Diagnostic Tool. PLoS ONE. 8(4). e60595–e60595. 39 indexed citations
13.
Barakat, Khaled, John Law, Wendy C. Magee, et al.. (2013). Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design. Journal of Chemical Information and Modeling. 53(11). 3031–3043. 24 indexed citations
14.
Steenbergen, Renske D.M., Michael Joyce, Bradley Thomas, et al.. (2013). Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers. Hepatology. 58(6). 1907–1917. 54 indexed citations
15.
Steffen, Imke, D. Lorne Tyrrell, Leilani Montalvo, et al.. (2011). No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome. PLoS ONE. 6(11). e27870–e27870. 16 indexed citations
16.
Moore, Penny L., Pippa Oakeshott, Jacqueline Logan, John Law, & D. M. Harris. (1990). Prophylaxis against hepatitis A for travel.. BMJ. 300(6726). 723–724. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026